TFXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

TELEFLEX INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$129.68−0.75 (-0.58%)

Close on Oct 19, 2026

Market cap: $5.66B
P/E (TTM): –
Dividend yield: 1.05%

TELEFLEX INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Revenue	1,993	1,700	1,712	2,791	2,810	2,537	2,595	2,448	2,146	1,868	1,810	1,840	1,696	1,551	1,493	1,398	1,435	1,912
Cost of Revenue	872	662	672	1,260	1,260	1,212	1,186	1,146	975	872	865	897	857	803	784	719	749	1,111
Gross Profit	1,121	1,037	1,040	1,531	1,550	1,325	1,409	1,303	1,172	996	944	942	839	748	709	679	686	802
Research & Development	145	109	114	154	131	120	114	106	85	59	52	61	65	56	49	42	37	33
Selling, General & Admin	720	675	623	864	860	744	852	797	700	563	569	579	502	454	424	404	388	503
Operating Income	118	104	259	500	628	423	427	322	372	319	316	285	233	-97	230	230	250	239
Interest Expense	100	84	85	54	57	66	80	103	83	55	61	65	57	70	70	80	89	122
Interest & Investment Income	6.40	6.15	12	0.91	1.33	1.16	1.74	0.94	0.77	0.47	0.53	0.71	0.62	1.57	1.26	0.72	2.48	2.27
Merger & Restructuring Charges	24	9.63	4.22	19	15	17	15	60	15	16	7.82	18	28	–	0.46	2.88	7.03	–
Asset Impairment Charges	108	7.83	0	1.50	6.74	21	6.97	19	–	43	0	0	11	332	2.50	–	3.36	–
Gain (Loss) on Sale of Assets	0	0	4.45	6.50	91	0	6.08	1.39	0	4.37	0.41	–	–	–	0.58	-0.34	0	–
Pretax Income	25	26	185	446	559	358	340	220	285	246	245	220	176	-165	145	105	164	120
Income Tax Expense	-34	-31	42	83	74	22	-122	23	130	8.07	7.84	29	24	16	26	17	37	38
Income from Continuing Operations	59	57	144	363	485	336	462	196	155	237	236	190	151	-183	118	87	126	81
Income from Discontinued Operations	-964	12	213	0.22	0.26	-0.48	-0.52	4.37	-2.73	0.19	8.91	-2.71	-0.44	-7.32	206	115	187	73
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	461	201	153	238	246	189	152	-189	325	202	314	155
Net Income	-906	70	356	363	485	335	461	201	153	237	245	188	151	-190	323	201	303	120
EPS (Basic)(per share)	-20.30	1.49	7.58	7.74	10.38	7.21	9.99	4.39	3.39	5.48	5.89	4.54	3.67	-4.65	7.98	5.04	7.63	3.03
EPS (Diluted)(per share)	-20.25	1.48	7.53	7.68	10.23	7.09	9.80	4.29	3.27	4.98	5.10	4.04	3.45	-4.65	7.92	4.99	7.59	3.01
Shares Outstanding (Basic, Weighted)(shares)	45	47	47	47	47	46	46	46	45	43	42	41	41	41	41	40	40	40
Shares Outstanding (Diluted, Weighted)(shares)	45	47	47	47	47	47	47	47	47	48	48	46	44	41	41	40	40	40
Dividend per Share(per share)	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.34
EBITDA	296	265	407	730	865	650	646	536	533	448	441	412	341	-2.49	326	320	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 54.9%
Operating margin: 2.0%
Net margin: -45.8%
Return on equity, FY2025: -24.5%

Financial strength

Current ratio: 2.60
Debt to equity: 0.97
Debt to assets: 41.4%
Cash to current liabilities: 41.7%

Valuation

P/E ratio: –
Price to sales: 2.51
Price to book: 1.95
Dividend yield: 1.05%